Outbreaks of highly pathogenic H5N1 avian influenza have been increasing since 2021, but in recent months have evolved into what is known as a 'global panzootic' affecting all types of wild birds and new continents, but also mammals such as mink and sea lions. At a briefing organised by SMC Germany, in collaboration with SMC UK and SMC Spain, three experts discussed the situation, the level of risk and possible next steps.
Several media outlets are reporting cases of "camel flu" or MERS-CoV at the World Cup in Qatar, including three French national team players. However, no cases have been confirmed and the news reports speak of non-specific symptoms that could be due to any other infectious condition. This coronavirus, discovered in 2012, has a high case fatality rate and before the start of the competition, the WHO had already asked fans travelling to the country to watch out for possible symptoms.
The H5N1 virus that is causing an unprecedented epidemic among wild and domestic birds has a very low capacity to infect humans. The three cases where infection has been found have been due to close contact with dust raised during the handling of affected poultry.
On 27 September, the National Microbiology Centre detected a positive H5N1 avian influenza in a worker at a poultry farm in Guadalajara (Castilla-La Mancha). The sample was taken on the 23rd and the affected person remained asymptomatic until he tested negative, according to Animal's Health.
The National Microbiology Centre has confirmed the first positive human case of H5N1 avian influenza detected in Spain, Animal's Health said yesterday. This is the worker of a poultry farm located in the province of Guadalajara who remained asymptomatic and isolated until he tested negative. This is the second case detected in Europe after the UK declared its case in January this year.
A sarbecovirus distantly related to SARS-CoV-2 and found in horseshoe bats in Russia is able to enter human cells using the ACE2 receptor, according to research published in PLOS Pathogens.
A study published in The Lancet Infectious Diseases analyses the response of seven monkeypox patients diagnosed in the UK between 2018-2021, treated with the antivirals brincidofovir and tecovirimat.
On 18 May, the Ministry of Health confirmed to SMC Spain that eight suspected cases "clinically compatible" with monkeypox had been detected. The same afternoon, the Consejería de Sanidad de la Comunidad de Madrid reported that it had detected 23 possible cases of infection. These cases need to be confirmed after testing. At least 7 cases have been confirmed in the UK and Portugal. This is a rare zoonotic viral disease and there is no vaccine or specific treatment available. Treatment is symptomatic and supportive. Most cases are resolved favourably.
Following the detection of several cases of people infected with the simian smallpox virus in the UK, health authorities are concerned that there may be EU-wide transmission with undetected infections, both within and outside the country. In Spain, the Community of Madrid has identified 23 possible cases of infection.
In the first months of 2022, avian influenza has hit birds in Spain with unprecedented intensity. All outbreaks are now closed and the epidemiological situation is favourable, but we must not let our guard down. The risk of the virus jumping to humans is considered low.